Cam Gallagher, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,900 shares at $42.31 ($834K) on 2022-03-15, disclosed to the SEC on 2022-03-16.
Open-market sale of $834k ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.45 | 4,578 | $190K | 22.7% |
| 2 | $41.45 | 4,578 | $190K | 22.7% |
| 3 | $42.31 | 5,322 | $225K | 27.0% |
| 4 | $42.31 | 5,322 | $225K | 27.0% |
| 5 | $43.18 | 100 | $4K | 0.5% |
| Total | $41.92 avg | 19,900 |
| $834K |
| 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |